Non-vitamin K antagonist oral anticoagulant use at doses inappropriately lower than recommended in outpatient older adults: a real-life data.

Erdogan T., Erdogan O., Ozturk S., Oren M. M., Karan M. A., BAHAT-ÖZTÜRK G.

European geriatric medicine, cilt.12, sa.4, ss.809-816, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12 Sayı: 4
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1007/s41999-021-00452-0
  • Dergi Adı: European geriatric medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.809-816
  • Anahtar Kelimeler: Atrial fibrillation, Inappropriate drug use, Low dose, Non-vitamin K antagonist oral anticoagulants
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background/Purpose There has been a rapid increase in the use of non-vitamin K-antagonist oral anticoagulants (NOAC). Current guidelines recommend dose adjustments be made in accordance with certain criteria for each NOAC. This study is aimed at determining whether or not NOAC were prescribed for non-valvular atrial fibrillation (AF) in guideline-recommended doses in community-dwelling older adults.